reassurance – Communicable Diseases Research

COVID-19 and the adaptive evolution of genetic counseling

코로나19와 유전자 상담의 적응적 진화

Article

Published on 2022-08-012022-09-11
Journal: Journal of genetic counseling [Category] 유전자 메커니즘,

A qualitative process analysis of daily contact testing as an alternative to self-isolation following close contact with a confirmed carrier of SARS-CoV-2

SARS-CoV-2의 확인된 보균자와의 긴밀한 접촉 후 자가 격리의 대안으로 일일 접촉 테스트의 정성적 프로세스 분석

Randomized Controlled Trial

Published on 2022-07-182022-09-11
Journal: BMC Public Health [Category] COVID19(2023년), SARS, 임상, 치료기술,

Immunity debt or vaccination crisis? A multi-method evidence on vaccine acceptance and media framing for emerging COVID-19 variants

면책 부채 또는 예방 접종 위기? 신종 코로나바이러스 감염증(COVID-19) 변종에 대한 백신 수용 및 미디어 프레이밍에 대한 다중 방법 증거

Article

Published on 2022-03-152022-09-11
Journal: Vaccine [Category] COVID19(2023년), SARS, 변종,

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma

다발성 골수종 환자에서 2 용량 SARS-COV-2 메신저 RNA 백신 접종에 대한 안전성 및 항체 반응

Research

Published on 2021-12-272022-09-01
Journal: BMC Cancer [Category] 진단,

The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study

알파 변종은 영국의 다기관 병원 연구에서 과도한 병원 내 SARS-CoV-2 감염과 관련이 없었습니다.

Multicenter Study

Published on 2021-12-012022-09-10
Journal: The Journal of Infection [Category] MERS, SARS, 변종,

[키워드] Alpha Alpha variant caused COG-UK collected Community community acquired COVID-19 determine Effect Efficacy epidemiological data Evidence genetic difference healthcare hospital hospitals Infection Infection prevention infections information investigated involved less Lineage Lineage B.1.1.7 lineages Logistic regression analysis measure nine no significant difference nosocomial Nosocomial outbreaks Nosocomial transmission objective outbreak overlapping Patient reassurance Result SARS-CoV-2 SARS-CoV-2 genome SARS-CoV-2 genome sequence SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 variant SARS-CoV-2 variants sequence sequence similarity Spread Support Transmissibility Transmission UK hospital UK hospitals variants of concern Viral viral sequence viral sequences
[DOI] 10.1016/j.jinf.2021.09.022 PMC 바로가기 [Article Type] Multicenter Study

Sampling for SARS-CoV-2 Aerosols in Hospital Patient Rooms

병원 환자 실에서 SARS-COV-2 에어로졸에 대한 샘플링

Article

Published on 2021-11-232022-09-10
Journal: Viruses [Category] MERS, SARS, 치료기술, 치료법,

[키워드] aerosol Aerosols airborne disease Chain Reaction Clinical characteristics collected COVID-19 COVID-19 patient Extracted floor foot gene region head hospital individual infected with SARS-CoV-2 investigated majority nine no significant differences nucleocapsid occupational participant Participants Patient patient room patient rooms Personal protective equipment polymerase chain polymerase chain reaction positive positive sample reassurance reverse transcription reverse transcription polymerase chain reaction room Safety sampling SARS-CoV-2 SARS-CoV-2 viral SARS-CoV-2 virus selected significant difference Spread the patient the SARS-CoV-2 virus Viral viral aerosols virus
[DOI] 10.3390/v13122347 PMC 바로가기 [Article Type] Article

Fears, Reassurance, and Milestones: A Twitter Analysis around World Prematurity Day during the COVID-19 Pandemic

Article

Published on 2021-10-142022-10-30
Journal: International Journal of Environmental Research an [Category] Coronavirus, MERS, SARS,

mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status

mRNA 백신 유도 T 세포는 우려되는 SARS-CoV-2 변이체에 동일하게 반응하지만 이전 감염 상태에 따라 수명과 귀환 특성이 다릅니다.

Research Article

Published on 2021-10-122022-09-10
Journal: eLife [Category] MERS, SARS, 변종,

[키워드] activate activated Analysis antibodies antibody Antigen-specific T cells B.1.1.7 B.1.351 B.1.351 variant best boost immunity booster dose both groups caused Cell changed Characteristics conducted convalescent coronavirus coronavirus SARS-CoV-2 COVID-19 COVID-19 convalescent donor COVID-19 convalescent donors CyTOF Cytometry determine dose doses elicit Epitopes Examining flight Focusing generate highlight homing Human identity Immune cell immune cells immune defense immune response immune system IMPROVE individuals Infection investigated killing longitudinal study Lungs Lymphocyte subsets mimicking MOST mRNA mRNA vaccine mRNA vaccines naïve vaccinees nasopharynx natural infection nose not need offer persistence phenotype Phenotypes phenotypic phenotypic feature phenotypic features Prevent PROTECT Protein Proteins quantity reassurance recognizing Research researcher respiratory tract respond SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2-specific T cell SARS-CoV-2-specific T cells second dose severe COVID-19 spike epitope spike epitopes spike-specific T cell Stimulation Strains surface protein surface proteins T cell T cell response T cells the cells the vaccine These cells two group two groups unique vaccination Vaccine vaccine dose vaccine doses vaccine-elicited T cell vaccinee vaccinees variant variants Viral Viral variants virus viruses while
[DOI] 10.7554/eLife.72619 PMC 바로가기 [Article Type] Research Article

Validation of the French IVF guidelines during the COVID-19 pandemic

COVID-19 전염병 동안 프랑스 IVF 지침의 유효성 검사

Comment

Published on 2021-09-012022-09-11
Journal: Reproductive biomedicine online [Category] SARS, 치료기술,

Therapeutic respiratory and functional rehabilitation protocol for intensive care unit patients affected by COVID-19: a structured summary of a study protocol for a randomised controlled trial

COVID-19의 영향을 받는 중환자실 환자를 위한 치료 호흡 및 기능 재활 프로토콜: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-04-122022-09-10
Journal: Trials [Category] MERS, 임상,

[키워드] 1:1 6-minute walk test activities activity Admission Adult patients affected age Agitation approved assessment balanced randomization blinded Blinding block blocks Borg both groups Care clinical status clinical trial Coma Comorbidities Comorbidity comparator conducted confidentiality cooperation COVID-19 criteria Critical Critical illness daily living Data collection defined discharge dissemination distribution of patient double-blind Douro Dyspnea Effect element eligible Endpoint evaluate evaluated evaluator exertion expected Follow-up for inclusion form functional functional capacity functional rehabilitation Glasgow coma scale group Handgrip strength test Health Health Service Health services Hospital stay Hospitalization Hospitalized hospitalized COVID-19 patients ICU incidence include independent intensive care intensive care unit Intervention intervention group life mechanical ventilation Medical Research Council Medicine Mobility Monday need for oxygen number Nurse nursing care objective occupational therapy occur outcome outcome measure outcomes oxygen Oxygen therapy participant Participants Patient per day Perceived physical Physical assessment physical rehabilitation Physiotherapist Physiotherapy Portugal positioning post-intensive care syndrome Potential Potential participants primary outcome measure progression protocol Quality of life question randomisation randomised randomised controlled trial randomization sequence Randomized Randomized controlled trial readmission reassurance receive recommendation recorded recruited referred to Registered registry rehabilitation rehabilitation exercises rehabilitation medicine respiratory respiratory insufficiency respiratory rehabilitation Respiratory system responsible Sample size Saturday scale Secondary objectives sequence Sex Society stability standard care Standard of care status strength test study group Study protocol subject suctioning supplementary material survey survival Test the patient therapy Tolerance treated Treatment Trial registration two groups verbal website
[DOI] 10.1186/s13063-021-05210-y PMC 바로가기 [Article Type] Letter